已核实 DOI PubMed 相关产品: 0

Expression, purification, and characterization of pneumococcal PsaA-PspA fusion protein

Journal 2020 · IF 1.513 · 发表于 2020 年 10 月 26 日
作者: Xiaonan Guo,Qing Sun,Hualong Xi,Yue Zhang,Mengze Guo,Chenxing Zhang,Shidong Zhu,Tiejun Gu,Wei Kong,Yongge Wu
阅读全文 在 PubMed 查看

摘要

Streptococcus pneumoniae is a gram-positive bacterial pathogen causing invasive pneumonia, meningitis, otitis media , and bacteremia . Owing to the current pitfalls of polysaccharide and polysaccharide-conjugate vaccines, protein vaccines are considered promising candidates against pneumonia. Pneumococcal surface protein A (PspA) and pneumococcal surface adhesin A (PsaA) are virulence proteins showing good immunogenicity and protective effects against S. pneumoniae strains in mice. In this study, we expressed the fusion protein PsaA-PspA, which consists of PsaA and the N-terminal region of PspA family 1 and 2, in Escherichia coli . We describe a novel and effective method to purify PsaA-PspA using hydroxyapatite and two-step chromatography . After determining the optimal induction conditions and a series of purification steps, we obtained PsaA-PspA fusion protein with over 95% purity at a final yield of 22.44% from the starting cell lysate. The molecular weight of PsaA-PspA was approximately 83.6 kDa and its secondary structure was evaluated by circular dichroism . Immunization with the purified protein induced high levels of IgG antibodies in mice. Collectively, these results demonstrate that our purification method can effectively produce high-purity PsaA-PspA fusion protein with biological activity and chemical integrity, which can be widely applied to the purification of other PspA subclass proteins.